PEGGX
Price
$20.90
Change
+$0.13 (+0.63%)
Updated
Jun 2 closing price
Net Assets
1.8B
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

PEGGX vs PMBCX

Header iconPEGGX vs PMBCX Comparison
Open Charts PEGGX vs PMBCXBanner chart's image
PEGGX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
PEGGX vs. PMBCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEGGX is a Hold and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. PEGGX (1.81B). PEGGX (0.00) and PMBCX (0.00) have matching dividends . PEGGX was incepted earlier than PMBCX: PEGGX (8 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than PEGGX (0.87). PEGGX is a more actively managed with annual turnover of: 65.00 vs. PMBCX (13.70). PEGGX has a lower initial minimum investment than PMBCX: PEGGX (0) vs PMBCX (1000). PEGGX annual gain was more profitable for investors over the last year : -2.17 vs. PMBCX (-15.11). PMBCX return over 5 years is better than : -9.16 vs. PEGGX (-25.02).
PEGGXPMBCXPEGGX / PMBCX
Total Expense Ratio0.831.7149%
Annual Report Gross Expense Ratio0.871.7151%
Fund Existence8 years19 years-
Gain YTD3.591-7.252-50%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.81B24.6B7%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.17-15.1114%
Returns for 3 years6.959.9770%
Returns for 5 years-25.02-9.16273%
Returns for 10 yearsN/A53.20-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity